Lv7
3490 积分 2021-12-21 加入
Obexelimab for the Treatment of IgG4-Related Disease
5天前
已完结
Ivonescimab Plus Chemo Extends Squamous NSCLC Survival
5天前
已关闭
Biliary Tract Cancers
18天前
已完结
Sacituzumab tirumotecan (Sac-TMT) plus pembrolizumab maintenance therapy in ovarian cancer: Results from the phase 22870-002/SKB264-II-06 study
23天前
已完结
Sacituzumab tirumotecan (Sac-TMT) plus pembrolizumab in participants with recurrent or metastatic cervical cancer: Results from the phase 22870-002/SKB264-II-06 study
23天前
已完结
Trastuzumab deruxtecan (T-DXd) for pretreated patients (pts) with HER2- expressing solid tumors: DESTINY-PanTumor02 (DP-02) Part 1 final analysis
1个月前
已关闭
Phase I, first-in-human study of AbGn-107, a novel antibody-drug conjugate (ADC), in patients with gastric, colorectal, pancreatic or biliary cancers
1个月前
已关闭
A multicenter phase Ia study of AbGn-107, a novel antibody–drug conjugate, in patients with advanced gastrointestinal cancer
1个月前
已完结
Tebotelimab plus niraparib in previously treated locally advanced or metastatic solid tumors: A phase 1b dose escalation and expansion study
1个月前
已完结
Tecotabart vedotin in Claudin 18.2-positive advanced gastric/gastroesophageal junction cancer: A Bayesian phase 1/2 clinical trial
1个月前
已完结
皖公网安备34019202002308
